Pseudothromboangiitis obliterons and qualitative protein C defect : A case report;Pseudothrombo-angéite oblitérante et déficit qualitatif en protéine C : A propos d'un cas

Journal des Maladies Vasculaires

Volumn 21, Issue 1, 1996, Pages 47-49

  Cailleux, N ^a   Guegan Massardier, E ^b   Borg, J Y ^b   Vasse, M ^b   Mihout, B ^b   Watelet, J ^b   Levesque, H ^a   Courtois, H ^a  

^a Dept de Médecine Interne Ctr Hosp Univ Rouen Boisguillaume   (France)

^b HÔPITAL CHARLES NICOLLE   (France)

Author keywords

Cerebral venous thrombosis; Protein C deficiency; Thromboangiitis obliterans

Indexed keywords

PROTEIN C;

ADULT; AGE; ARTICLE; BLOOD CLOTTING DISORDER; BRAIN VEIN; BUERGER DISEASE; CASE REPORT; DIFFERENTIAL DIAGNOSIS; HUMAN; MALE; PROTEIN C DEFICIENCY; THROMBOSIS; PATHOPHYSIOLOGY;

ADULT; HUMANS; MALE; PROTEIN C DEFICIENCY; THROMBOANGIITIS OBLITERANS;

EID: 0029690214     PISSN: 03980499     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. AIACH M, GANDRILLE S, EMMERICH J. A review of mutations causing deficiencies of antithrombin, protein C and protein S. Thromb Haemost 1995 ; 74 : 81-9.
2. ALARCON-SEGOVIA D, SANCHEZ-GUERRERO J. Primary antiphospholipid syndrome. J Rheumatol 1989 ; 16 : 482-8.
3. ASHERSON RA, KHAMASHTA MA, ORDI-ROS J, DERKSEN RHWM, MACHIN SJ, BARQUINERO J, OUTT HH, HARRIS EN, VIDARELL-TORRES M, HUGHES GR. The « primary » antiphospholipid syndrome : major clinical and serological features. Medicine 1989 ; 68 : 366-74.
4. BEZEAUD A, GUILLIN MC. Le système protéine C, protéine S, thrombomoduline en pathologie thrombotique. Sang, Thrombose, Vaisseaux 1990 ; 2 : 9-12.
5. CAILLEUX N, LEVESQUE H, GIBERT P, JOLY P, LAURET Ph, TESTART J, WATELET J, COURTOIS H. Les nécroses digitales du membre supérieur en dehors de la sclérodermie. Etude rétrospective, à propos de 45 observations. J Mal Vasc 1994 ; 19 : 22-6.
6. CASELLAS M, PEREZ A, CABERO L, SEGURA A, PUIG de MORALES E, SELVA O'CALLAGHAN R. Buerger's disease and antiphospholipid antibodies in pregnancy. Ann Rheum Dis 1993 ; 52 : 247-8.
7. DEHAINE-BAMBERGER N, AMAR R, TOUBOUL C, EMMERICH J, FIESSINGER JN. Maladie de Buerger, aspects cliniques et pronostiques. Quatre-vingt-trois observations. Presse Méd 1993 ; 22 : 945-8.
8. GUILMOT JL, LASFARGUES G. Maladie de Buerger ou thromboangéite oblitérante. Rev Prat 1988 ; 88 : 349-56.
9. HARRIS EN, BAGULEY E, ASHERSON RA, HUGHES GRV. Clinical and serological features of the antiphospholipid syndrome (APS) (abstract). Br J Rheumatol 1987 ; 26 : 19.
10. LINBLAD B, SVENSSON PJ, DAHLBACK B. Arterial and venous thromboembolism with fatal outcome and resistance to activated protein C. Lancet 1994 ; 343 : 917.
11. MCKUSICK VA, HARRIS WS, OTTESEN OE, GOODMAN RM, SHELLEY WM, BLOODWELL RD. Buerger's disease : a distinct clinical and pathologic entity. JAMA 1962 ; 181 : 93-100.
12. RIDKER PM, HENNEKENS CH, LINDPAINTNER K, STAMPFER MJ, EISENBERG PR, MILETICH JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 1995 ; 332 : 912-7.
13. SHORTELL CK, OWIEL K, GREEN RM, CONDEMI JJ, DeWEESE JA. Vascular disease in the antiphospholipid syndrome : a comparison with the patient population with atherosclerosis. J Vasc Surg 1992 ; 15 : 158-66.
14. TRIPLETT DA. Antiphospholipid antibodies and thrombosis. Arch Pathol Lab Med 1993 ; 117 : 78-88.
15. WIESEL ML, BORG JY, GRUNEBAUM L, VASSE M, LEVESQUE H, BIERME R, SIE P. Influence du déficit constitutionnel en protéine S sur le risque thrombotique artériel. Presse Méd 1991 ; 20 : 1023-7.